Cell Viability Assays Market to Accrue Exponentially By Registering ~ 9.2% CAGR during the Forecast Period 2017-2023
Jan 15, 2019
A new market study, titled “Cell Viability Assays Market Research Report – Forecast to 2023” has been featured on Market Research Future.
Pune, India - January 15, 2019 /MarketersMedia/ —
Market Scenario:
Global Cell Viability Assays market is expected to grow significantly over the forecast period. It is estimated that the global cell Viability Assays market is expected to register a CAGR ~ 9.2% during the forecast period of 2018–2023.
Cell-based assays are techniques used for the screening collections of compounds to find out if the test molecules have any effect on cell proliferation or show direct cytotoxic effects that eventually lead to cell death. The measurement of cell viability plays a significant role in all forms of cell culture. The main application of cell viability is to determine whether the cells are alive. For instance, in cancer research, cell viability assays are used to confirm the killing of tumor cells and to verify the survival of normal cells.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6391
Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market. For instance, in 2015, the National Institutes of Health invested around 1,429 million USD for stem cells research. Moreover, increasing focus on developing cell-based therapeutics boosts the growth of the market. However, the rising cost of the instruments may hamper the market growth during the assessment period.
Key Players
Thermo Fisher Scientific
Merck KGaA
Bio-Rad Laboratories
G E Healthcare
Danaher Corporation
Becton, Dickinson and Company
Promega Corporation
Biotium
Abcam plc
Creative Bioarray
Biotek Instruments
PerkinElmer
Regional Market
Geographically, the Americas is anticipated to dominate the global cell Viability Assays market owing to a well-developed healthcare sector, rising prevalence of infectious and chronic diseases and growing healthcare expenditure. According to an article published by the Centers for Medicare and Medicaid Services in August 2018, the US healthcare spending had reached USD 3.3 trillion in 2016. Europe is expected to hold the second largest position in the global cell Viability Assays market. The market growth in this region is attributed to the growing prevalence of chronic diseases and increasing healthcare expenditure. According to a report published by EU observer in September 2014, more than the one-third population of Europe above the age of 15 years in suffering from a chronic disease and 2 in every 3 people reaching the age of retirement have at least 2 chronic diseases.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising number of stem cell, proteomics, and genomics research activities. Also, increased expenditure in the healthcare sector is expected to boost the growth in this market.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Segmentation
The market has been segmented into products, cell type, applications, and end-user.
The market, on the basis of products, has been segmented into consumables and instruments.
The consumables segment has been further divided into reagents, assay kits, and microplates. The Assay kits segment has been further segmented into tetrazolium reduction assay kits, resazurin cell Viability Assays kits, calcein-Am cell Viability Assays kits and other assay kits. Furthermore, tetrazolium assay kits have been classified into MIT assay kits and other tetrazolium assay kits.
The instruments have been segmented into automated cell counters, flow cytometers, spectrophotometers, and cell imaging & analysis systems.
The market, by applications, has been segmented into stem cell research, clinical & diagnostic applications, drug discovery & development, and others.
The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospital & diagnostic laboratories and others.
The market, by cell type, has been segmented into human cells, microbial cells, and animal cells.
The European cell Viability Assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The cell Viability Assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cell Viability Assays market in the Middle East & Africa has been segmented into the Middle East and Africa.
Browse Complete 90 Pages Premium Research Report Enabled with 92 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cell-viability-assays-market-6391
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6391
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Contact Us:, https://www.marketresearchfuture.com, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar,, Pune - 411028, Maharashtra, India, Phone: +1 646 845 9312, Email: [email protected]
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/cell-viability-assays-market-6391
Source: MarketersMedia
Release ID: 470741
More News
Kent-born darts star crowned European champion for second time
Kent-born darts star Ross Smith has reclaimed his European Championship crown after defeating Martin Schindler in a thrilling final in Dortmund.
‘That can’t be happening’ – Hale on Gillingham’s 4-1 defeat
Striker Ronan Hale says Gillingham must learn to respond better to setbacks after admitting their heads dropped during Saturday’s 4-1 defeat.
Ashford’s historic bowls club edges closer to new home as work begins on clubhouse
Work has begun on a new bowls clubhouse as members edge closer to leaving their existing home of almost 120 years.
Report: Gillingham thrashed by Grimsby again
Gillingham’s woes against Grimsby Town continued with another home thrashing against the visitors.
Ainsworth lets Gillingham players have it after Grimsby humiliation
Manager Gareth Ainsworth admitted he was as frustrated as the Gillingham fans after Saturday’s heavy defeat.
Matchday Live: Gillingham v Grimsby, Torquay v Maidstone, Ebbsfleet v Maidenhead, Folkestone v Farnborough
Follow today’s football action, including Gillingham’s match at home to Grimsby, in our live blog.
Chatham prepare for top-two test after Dulwich demolition
Chatham Town welcome second-placed Welling United to the Bauvill on Saturday looking to build on their midweek thrashing of Dulwich Hamlet.
Ainsworth wants new-look Gills to right Grimsby wrongs
Manager Gareth Ainsworth wants Gillingham to put past Grimsby misery behind them when the Mariners return to Priestfield on Saturday.
Injury boost as Gillingham players close in on comebacks
Gillingham captain Liam Gordon is one of four injured players closing in on a return to action.
‘We had a point to prove’ – Gillingham defender on Port Vale response
Defender Andy Smith admitted the Gills had let themselves down last weekend but was pleased with their response against Port Vale.
Football fixtures and results
Catch up with all the week’s football fixtures and results.
Ainsworth pinpoints moment Gillingham missed their chance
Gillingham manager Gareth Ainsworth was left to rue the big missed chance that let visitors Port Vale off the hook.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.